Nuvectis Pharma reported higher Q2 2026 revenue and outlined operational progress as it advances its business strategy. A key recent milestone: China approved C

Nuvectis Pharma reported higher Q2 2026 revenue and outlined operational progress as it advances its business strategy. A key recent milestone: China approved Ciprocopan in April for PNH patients not previously treated with complement inhibitors.